Hong Kong Pharmaceuticals & Biotech Most Searched for companies on Simply Wall St (do not delete)

Abbisko Cayman

Market Cap: HK$9.1b

Engages in the research and development of pharmaceutical products in the People’s Republic of China and the European Union.

Vigonvita Life Sciences

Market Cap: HK$5.5b

A commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule drugs for neuropsychiatry, reproductive health, and viral infection therapeutic areas.

Tong Ren Tang Technologies

Market Cap: HK$5.8b

Produces and distributes Chinese medicine products in Mainland China and Hong Kong.

Fujian Haixi Pharmaceuticals

Market Cap: HK$10.5b

Manufactures and sells pharmaceutical drugs in China.

Antengene

Market Cap: HK$2.8b

A clinical-stage APAC biopharmaceutical company, develops novel oncology therapies in Greater China and internationally.

CK Life Sciences Int'l. (Holdings)

Market Cap: HK$8.0b

An investment holding company, researches, develops, manufactures, commercializes, and sells health and agriculture-related products in the Asia Pacific and North America.

China NT Pharma Group

Market Cap: HK$559.6m

An investment holding company, engages in the investment, research and development, manufacture, sale, and distribution of pharmaceutical products in the People’s Republic of China.

Ascletis Pharma

Market Cap: HK$12.9b

A biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China.

Immunotech Biopharm

Market Cap: HK$1.8b

A cellular immunotherapy biopharmaceutical company, focuses on the research, development, and commercialization of T cell immunotherapy products for the treatment of cancers in the People’s Republic of China.

3D Medicines

Market Cap: HK$1.2b

A biopharmaceutical company, researches, develops, and commercializes oncology products and other drug candidates for the treatment of patients with various cancers in the People’s Republic of China.

Jacobio Pharmaceuticals Group

Market Cap: HK$7.1b

An investment holding company, engages in the in-house discovery and development of oncology therapies.

SinoMab BioScience

Market Cap: HK$2.1b

A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of therapeutics for the treatment of immunological diseases primarily monoclonal antibody (mAb)-based biologics in Mainland China and Hong Kong.

SSY Group

Market Cap: HK$8.6b

An investment holding company, researches, develops, manufactures, trades in, and sells various pharmaceutical products to hospitals and distributors in the People’s Republic of China and internationally.

CStone Pharmaceuticals

Market Cap: HK$8.9b

A biopharmaceutical company, researches and develops anti-cancer therapies to address the unmet medical needs of cancer patients in Mainland China and internationally.

China Health Group

Market Cap: HK$154.3m

An investment holding company, researches and develops drugs, bio drugs, natural drugs, and synthetic drugs in the People’s Republic of China.

Tianda Pharmaceuticals

Market Cap: HK$245.1m

Engages in the research and development, manufacture, and sale of pharmaceutical, biotechnology, and healthcare products in Mainland China, Hong Kong, and Australia.

InnoCare Pharma

Market Cap: HK$25.9b

A biopharmaceutical company, engages in discovering, developing, and commercializing drugs for the treatment of cancer and autoimmune diseases in China.

Uni-Bio Science Group

Market Cap: HK$698.6m

An investment holding company, researches and develops, manufactures, and sells biological and chemical pharmaceutical products to treat human diseases in the People’s Republic of China.

Shanghai Haohai Biological Technology

Market Cap: HK$10.4b

Shanghai Haohai Biological Technology Co., Ltd.

Sunho Biologics

Market Cap: HK$1.0b

A biopharmaceutical company, engages in the discovery, development, and commercialization of biologics that regulate immune microenvironment by modulating the innate and adaptive immune systems.

Genscript Biotech

Market Cap: HK$28.9b

An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.

HighTide Therapeutics

Market Cap: HK$1.5b

A clinical-stage biopharmaceutical company, focuses on the development of therapies to treat patients with chronic metabolic and liver diseases in Mainland China.

Laekna

Market Cap: HK$6.5b

An investing holding company, engages in the discovering, development, and commercialization of therapies for patients with cancer, metabolic diseases, and liver fibrosis in the People’s Republic of China, the United States of America, and South Korea.

Shenzhen Neptunus Interlong Bio-technique

Market Cap: HK$256.7m

Engages in the research and development, manufacturing, and selling of medicines and medical devices in the People’s Republic of China.

Alphamab Oncology

Market Cap: HK$10.6b

A biopharmaceutical company, engages in the research, development, manufacture, and commercialization of biotherapeutics for cancer treatment in the People’s Republic of China.

Biosino Bio-Technology and Science Incorporation

Market Cap: HK$303.9m

Manufactures, sells, and distributes in-vitro diagnostic reagents in Mainland China.

CanSino Biologics

Market Cap: HK$12.9b

Develops, manufactures, and commercializes vaccines in the People’s Republic of China.

Nanjing Leads Biolabs

Market Cap: HK$10.0b

A clinical-stage biotechnology company, engages in the research, development, and commercialisation of novel antibody drugs worldwide.

Zhongzhi Pharmaceutical Holdings

Market Cap: HK$492.3m

An investment holding company, engages in the research, development, manufacture, and sale of pharmaceutical products in the People’s Republic of China.

GenFleet Therapeutics (Shanghai)

Market Cap: HK$10.0b

Operates as a biopharmaceutical company that focuses on developing novel treatment options in the fields of oncology that cover different lines of treatments of multiple solid tumors, as well as autoimmune and inflammatory diseases.

Shanghai Bao Pharmaceuticals

Market Cap: HK$23.8b

A clinical-stage biotechnology company uses synthetic biology technology to develop and deliver recombinant biologic drugs in Mainland China, Hong Kong, Macau, and Taiwan.

WuXi XDC Cayman

Market Cap: HK$87.9b

An investment holding company, operates as a contract research, development, and manufacturing organization in China, North America, Europe, and internationally.

Clover Biopharmaceuticals

Market Cap: HK$3.3b

A biotechnology company, engages in the research and development, manufacture, and commercialization of vaccines in Mainland China and internationally.

CANbridge Pharmaceuticals

Market Cap: HK$980.8m

A biopharmaceutical company, engages in the research, development, and commercialization of therapies for rare diseases and oncology indications worldwide.

Beijing Biostar Pharmaceuticals

Market Cap: HK$713.0m

A synthetic biology-driven biopharmaceutical company, engages in the research, development, manufacture, and commercialization of oncology products in the People’s Republic of China.

Wuhan YZY Biopharma

Market Cap: HK$1.4b

A biotechnology company, develops bispecific antibody-based therapies for the treatment of cancer, cancer-related complications, and age-related ophthalmologic diseases.